CoChat

Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma

Open access
Harder, Nathalie, Schönmeyer, Ralf, Nekolla, Katharina, Meier, Armin, Brieu, Nicolas, Vanegas, Carolina, Madonna, Gabriele, Capone, Mariaelena, Botti, Gerardo, Ascierto, Paolo A., Schmidt, Günter · 2019 · Scientific Reports
Cited by 56

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

In the context of precision medicine with immunotherapies there is an increasing need for companion diagnostic tests to identify potential therapy responders and avoid treatment coming along with severe adverse events for non-responders. Here, we present a retrospective case study to discover image-based signatures for developing a potential companion diagnostic test for ipilimumab (IPI) in malignant melanoma. Signature discovery is based on digital pathology and fully automatic quantitative image analysis using virtual multiplexing as well as machine learning and deep learning on whole-slide images. We systematically correlated the patient outcome data with potentially relevant local image features using a Tissue Phenomics approach with a sound cross validation procedure for reliable performance evaluation. Besides uni-variate models we also studied combinations of signatures in several multi-variate models. The most robust and best performing model was a decision tree model based on relative densities of CD8+ tumor infiltrating lymphocytes in the intra-tumoral infiltration region. Our results are well in agreement with observations described in previously published studies regarding the predictive value of the immune contexture, and thus, provide predictive potential for future development of a companion diagnostic test.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-43525-8

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 28

  1. Larkin, J. et al. Combined Nivolumab and Ipilimumab or Monotherapy in Previously Untreated Melanoma. N. Engl. J. Med. 373, 23–34 (2015). · DOI · Paper page
  2. Teixidó, C., González-Cao, M., Karachaliou, N. & Rosell, R. Predictive factors for immunotherapy in melanoma. Ann. Transl. Med. 3, 208 (2015).
  3. Ladányi, A. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma. Pigment Cell Melanoma Res. 28, 490–500 (2015). · DOI · Paper page
  4. Espinosa, E. et al. Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM). Ann. Transl. Med. 5, 389 (2017). · DOI
  5. Ascierto, P. A., Kalos, M., Schaer, D. A., Callahan, M. K. & Wolchok, J. D. Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types. Clin. Cancer Res. 19, 1009 (2013). · DOI · Paper page
  6. Ji, R.-R. et al. An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunol. Immunother. 61, 1019–1031 (2012). · DOI · Paper page
  7. Snyder, A. et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N. Engl. J. Med. 371, 2189–2199 (2014). · DOI · Paper page
  8. Galon, J. et al. Cancer classification using the Immunoscore: a worldwide task force. J. Transl. Med. 10, 205 (2012). · DOI · Paper page
  9. Capone, M. et al. Immunoscore: a new possible approach for melanoma classification. J. Immunother. Cancer 2, P193–P193 (2014). · doi:10.1186/2051-1426-2-s3-p193
  10. Bifulco, C. et al. MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab. J. Transl. Med. 12, P11 (2014). · doi:10.1186/1479-5876-12-s1-p11
  11. Galon, J. et al. Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015. J. Transl. Med. 14, 273 (2016). · DOI · Paper page
  12. Madonna, G. et al. PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab. OncoImmunology e1405206, https://doi.org/10.1080/2162402X.2017.1405206 (2017). · DOI · Paper page
  13. Harder, N. et al. Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer. Sci. Rep. 8, 4470 (2018). · DOI
  14. Harder, N. et al. Optimal Patient Selection for Immunotherapy in Melanoma using Tissue Phenomics. In Proc. 6th European Post-Chicago Melanoma/Skin Cancer Meeting (2016).
  15. Brieu, N., Pauly, O., Zimmermann, J., Binnig, G. & Schmidt, G. Slide-specific models for segmentation of differently stained digital histopathology whole slide images. In Proc. SPIE Medical Imaging 2016: Image Processing (eds Styner, M. A. & Angelini, E. D.) 9784, 978410-978410–7 (SPIE, 2016). · DOI
  16. Criminisi, A., Shotton, J. & Bucciarelli, S. Decision Forests with Long-Range Spatial Context for Organ Localization in CT Volumes. In MICCAI workshop on Probabilistic Models for Medical Image Analysis (MICCAI-PMMIA) 69–80 (2009).
  17. Yigitsoy, M., Schmidt, G. & Binnig, G. Hierarchical patch-based co-registration of differently stained histopathology slides. in Medical Imaging 2017: Digital Pathology, Proc. SPIE (2017). · DOI
  18. Russakovsky, O. et al. ImageNet Large Scale Visual Recognition Challenge. Int. J. Comput. Vis. IJCV 115, 211–252 (2015). · DOI · Paper page
  19. Szegedy, C. et al. Going deeper with convolutions. In 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) 1–9, https://doi.org/10.1109/CVPR.2015.7298594 (IEEE, 2015) · DOI · Paper page
  20. Hermitte, F. Biomarkers immune monitoring technology primer: Immunoscore® Colon. J. Immunother. Cancer 4, 57–57 (2016). · DOI
  21. Breiman, L., Friedman, J., Stone, C. J. & Olshen, R. A. Classification and Regression Trees. (Taylor & Francis Ltd, 1984).
  22. Vapnik, V. N. The nature of statistical learning theory. (Springer, 1995). · DOI · Paper page
  23. Cox, D. R. The Regression Analysis of Binary Sequences. J. R. Stat. Soc. Ser. B Methodol. 20, 215–242 (1958). · DOI · Paper page
  24. Jia, Y. et al. Caffe: Convolutional Architecture for Fast Feature Embedding. ArXiv Prepr. ArXiv14085093 (2014). · DOI · Paper page
  25. Pedregosa, F. et al. Scikit-learn: Machine Learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
  26. Franklin, C., Livingstone, E., Roesch, A., Schilling, B. & Schadendorf, D. Immunotherapy in melanoma: Recent advances and future directions. New Roads Melanoma Manag. 43, 604–611 (2017).
  27. Berthel, A. et al. Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival. OncoImmunology 6, e1286436 (2017). · DOI
  28. Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014). · DOI · Paper page

Cited by

See all 56

Metadata

Authors
Harder, N., Schönmeyer, R., Nekolla, K., Meier, A., Brieu, N., Vanegas, C., Madonna, G., Capone, M., Botti, G., Ascierto, P. A., & Schmidt, G.
Venue
Scientific Reports
Published
2019-05-15
Volume
9
Issue
1
Pages
7449-7449
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2946404782
Cited by
56
References
4
FWCI
2.88
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma. https://app.cochat.ai/papers/10.1038/s41598-019-43525-8
The paper
Harder, N., Schönmeyer, R., Nekolla, K., Meier, A., Brieu, N., Vanegas, C., Madonna, G., Capone, M., Botti, G., Ascierto, P. A., & Schmidt, G. (2019). Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma. Scientific Reports. https://doi.org/10.1038/s41598-019-43525-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.